PURPOSE OF REVIEW: Executive functions represent a constellation of cognitive abilities that drive goal-oriented behavior and are critical to the ability to adapt to an ever-changing world. This article provides a clinically oriented approach to classifying, localizing, diagnosing, and treating disorders of executive function, which are pervasive in clinical practice. RECENT FINDINGS: Executive functions can be split into four distinct components: working memory, inhibition, set shifting, and fluency. These components may be differentially affected in individual patients and act together to guide higher-order cognitive constructs such as planning and organization. Specific bedside and neuropsychological tests can be applied to evaluate components of executive function. While dysexecutive syndromes were first described in patients with frontal lesions, intact executive functioning relies on distributed neural networks that include not only the prefrontal cortex, but also the parietal cortex, basal ganglia, thalamus, and cerebellum. Executive dysfunction arises from injury to any of these regions, their white matter connections, or neurotransmitter systems. Dysexecutive symptoms therefore occur in most neurodegenerative diseases and in many other neurologic, psychiatric, and systemic illnesses. Management approaches are patient specific and should focus on treatment of the underlying cause in parallel with maximizing patient function and safety via occupational therapy and rehabilitation. SUMMARY: Executive dysfunction is extremely common in patients with neurologic disorders. Diagnosis and treatment hinge on familiarity with the clinical components and neuroanatomic correlates of these complex, high-order cognitive processes.
PURPOSE OF REVIEW: Executive functions represent a constellation of cognitive abilities that drive goal-oriented behavior and are critical to the ability to adapt to an ever-changing world. This article provides a clinically oriented approach to classifying, localizing, diagnosing, and treating disorders of executive function, which are pervasive in clinical practice. RECENT FINDINGS: Executive functions can be split into four distinct components: working memory, inhibition, set shifting, and fluency. These components may be differentially affected in individual patients and act together to guide higher-order cognitive constructs such as planning and organization. Specific bedside and neuropsychological tests can be applied to evaluate components of executive function. While dysexecutive syndromes were first described in patients with frontal lesions, intact executive functioning relies on distributed neural networks that include not only the prefrontal cortex, but also the parietal cortex, basal ganglia, thalamus, and cerebellum. Executive dysfunction arises from injury to any of these regions, their white matter connections, or neurotransmitter systems. Dysexecutive symptoms therefore occur in most neurodegenerative diseases and in many other neurologic, psychiatric, and systemic illnesses. Management approaches are patient specific and should focus on treatment of the underlying cause in parallel with maximizing patient function and safety via occupational therapy and rehabilitation. SUMMARY: Executive dysfunction is extremely common in patients with neurologic disorders. Diagnosis and treatment hinge on familiarity with the clinical components and neuroanatomic correlates of these complex, high-order cognitive processes.
Authors: Jessica J M Barnes; Angela J Dean; L Sanjay Nandam; Redmond G O'Connell; Mark A Bellgrove Journal: Biol Psychiatry Date: 2011-03-11 Impact factor: 13.382
Authors: Katherine L Possin; Amanda K LaMarre; Kristie A Wood; Dan M Mungas; Joel H Kramer Journal: J Int Neuropsychol Soc Date: 2013-06-14 Impact factor: 2.892
Authors: Katherine L Possin; Tacie Moskowitz; Sabrina J Erlhoff; Kirsten M Rogers; Erica T Johnson; Natasha Z R Steele; Joseph J Higgins; Jordan Stiver; Andrea G Alioto; Sarah T Farias; Bruce L Miller; Katherine P Rankin Journal: J Am Geriatr Soc Date: 2018-01 Impact factor: 5.562
Authors: Amal Al-Lozi; Susan Searles Nielsen; Tamara Hershey; Angela Birke; Harvey Checkoway; Susan R Criswell; Brad A Racette Journal: Am J Ind Med Date: 2016-11-15 Impact factor: 2.214
Authors: Dima A Hammoud; Sanhita Sinharay; Sally Steinbach; Paul G Wakim; Katrina Geannopoulos; Katherine Traino; Amit K Dey; Edmund Tramont; Stanley I Rapoport; Joseph Snow; Nehal N Mehta; Bryan R Smith; Avindra Nath Journal: Neurology Date: 2018-09-26 Impact factor: 9.910
Authors: Madeline N Rockhold; Alyssa M Krueger; Erik de Water; Christopher W Lindgren; Kristin E Sandness; Judith K Eckerle; Mariah J Schumacher; Birgit A Fink; Christopher J Boys; Stephanie M Carlson; Anita J Fuglestad; Sarah N Mattson; Kenneth L Jones; Edward P Riley; Jeffrey R Wozniak Journal: Alcohol Clin Exp Res Date: 2021-01-22 Impact factor: 3.455
Authors: Brent Bluett; Alexander Y Pantelyat; Irene Litvan; Farwa Ali; Diana Apetauerova; Danny Bega; Lisa Bloom; James Bower; Adam L Boxer; Marian L Dale; Rohit Dhall; Antoine Duquette; Hubert H Fernandez; Jori E Fleisher; Murray Grossman; Michael Howell; Diana R Kerwin; Julie Leegwater-Kim; Christiane Lepage; Peter Alexander Ljubenkov; Martina Mancini; Nikolaus R McFarland; Paolo Moretti; Erica Myrick; Pritika Patel; Laura S Plummer; Federico Rodriguez-Porcel; Julio Rojas; Christos Sidiropoulos; Miriam Sklerov; Leonard L Sokol; Paul J Tuite; Lawren VandeVrede; Jennifer Wilhelm; Anne-Marie A Wills; Tao Xie; Lawrence I Golbe Journal: Front Neurol Date: 2021-07-01 Impact factor: 4.003